Premium
Ethical Issues in the Biotechnology and Pharmaceutical Industries
Author(s) -
Aronson Debra,
Best Simon G.,
Werner Michael J.,
Moos Walter H.
Publication year - 2004
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.10403
Subject(s) - bioethics , openness to experience , engineering ethics , theme (computing) , ethical issues , audit , political science , environmental ethics , sociology , microbiology and biotechnology , business , engineering , law , psychology , biology , computer science , accounting , social psychology , philosophy , operating system
Ethical topics come in many shapes and forms. When we set out to identify potential areas for the present special issue of this journal, we considered many areas that fit within a theme of “future challenges in bioethics.” We were interested in the impact of new technologies, how society will cope, how institutions will change to deal with the issues, and how different parts of the world will view the same issues differently. In this preface, we briefly describe selected issues, including scientific openness, genetics and related areas, informed consent and privacy, and human rights in the third world. We also mention corporate ethics, an area of much recent attention in the media, at corporations, with auditors, and on Wall Street. Finally, we describe the areas covered by the specific articles that follow. Drug Dev Res 63:89–92, 2004. © 2005 Wiley‐Liss, Inc.